Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study

B Pasternak, V Wintzell, M Melbye, B Eliasson… - bmj, 2020 - bmj.com
Objective To assess the association between use of sodium-glucose co-transporter 2
(SGLT2) inhibitors and risk of serious renal events in data from routine clinical practice …
被引用次数：84 相关文章

Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study

B Pasternak, V Wintzell, M Melbye… - BMJ (Clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective To assess the association between use of sodium-glucose co-transporter 2
(SGLT2) inhibitors and risk of serious renal events in data from routine clinical practice …
[PDF] core.ac.uk

[PDF][PDF] Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study

B Pasternak, V Wintzell, M Melbye, B Eliasson… - bmj, 2020 - core.ac.uk
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian
cohort study Page 1 univERsity oF copEnhAGEn Use of sodium-glucose co-transporter 2 …

Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study

B Pasternak, V Wintzell, M Melbye… - BMJ: British Medical …, 2020 - search.proquest.com
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian
cohort study Page 1 the bmj | BMJ 2020;369:m1186 | doi: 10.1136/bmj.m1186 1 RESEARCH …
[PDF] archive.org

[PDF][PDF] Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study

B Pasternak, V Wintzell, M Melbye, B Eliasson… - bmj, 2020 - scholar.archive.org
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian
cohort study Page 1 univERsity oF copEnhAGEn Use of sodium-glucose co-transporter 2 …

Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events

B Pasternak, V Wintzell, M Melbye, B Eliasson… - BMJ: British Medical …, 2020 - JSTOR
OBJECTIVE To assess the association between use of sodiumg-lucose co-transporter 2
(SGLT2) inhibitors and risk of serious renal events in data from routine clinical practice …
[HTML] bmj.com

[HTML][HTML] Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study

B Pasternak, V Wintzell, M Melbye, B Eliasson… - BMJ, 2020 - bmj.com
Objective To assess the association between use of sodium-glucose co-transporter 2
(SGLT2) inhibitors and risk of serious renal events in data from routine clinical practice …
[PDF] unit.no

[PDF][PDF] Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study

B Pasternak, V Wintzell, M Mellbye, B Eliasson… - 2020 - fhi.brage.unit.no
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian
cohort study Page 1 the bmj | BMJ 2020;369:m1186 | doi: 10.1136/bmj.m1186 1 RESEARCH …

Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study

B Pasternak, V Wintzell, M Melbye, B Eliasson… - BMJ, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Objective</jats: title>< jats: p> To
assess the association between use of sodium-glucose co-transporter 2 (SGLT2) inhibitors …
[HTML] nih.gov

[HTML][HTML] Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study

B Pasternak, V Wintzell, M Melbye, B Eliasson… - The BMJ, 2020 - ncbi.nlm.nih.gov
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events:
Scandinavian cohort study - PMC Back to Top Skip to main content NIH NLM Logo Access keys …